Detalimogene gene therapy shows promising results in bladder cancer trialByKeith LoriaJanuary 9th 2026
Self-driven electrical triggering system enhances drug delivery in bladder cancer therapyByKeith LoriaDecember 3rd 2025
Relmada Therapeutics appoints Max Kates to clinical advisory board to support NDV-01 phase 3 program for bladder cancerByKeith LoriaNovember 22nd 2025